Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep437 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Association of FGF21 soluble levels with metabolic profile in Gestational Diabetes patients

Saucedo-Toral Cristian A. , Lazo-de-la-Vega-Monroy Maria L. , Fajardo-Araujo Martha E. , Espinosa-Nava Manuel A. , Anaya-Torres Francisco J. , Ibarra-Reynoso Lorena del R. , Ruiz-Noa Yeniley

Introduction: Gestational Diabetes Mellitus (GDM) has been associated with complications both in the neonate and in the mother; including increased risk of Type 2 Diabetes Mellitus (DM2), obesity, and cardiovascular disease. Fibroblast growth factor 21 (FGF21) is a key regulator of glucose and lipid metabolism. Recently, the relationship between FGF21 and metabolic component diseases such as diabetes mellitus and obesity has been demonstrated. In addition, FGF21 mRNA and prote...

ea0049ep569 | Diabetes complications | ECE2017

Diabetic choroidopathy and renal function

Hermosilla Antonio Manuel Garrido , Muros Mariola Mendez , Portillo Cristobal Morales , Hernandez Tomas Martin , Rivera Natividad Gonzalez , Granda Maria Jesus Diaz , de la Rua Franch Enrique Rodriguez , Sanchez Estanislao Gutierrez

Objectives: Examine the relationship between choroidal thickness (CT) and renal function tests.Methods: Cross-sectional study with 42 eyes of 21 ocular treatment-naïve diabetic patients. Demographic and ocular data were analyzed as well as the following renal function tests: microalbuminuria, microalbumin/creatinine ratio and glomerular filtration rate (CKD-EPI and MDRD-4). Choroidal thickness was measured by swept-source ocular coherence tomography...

ea0049ep666 | Obesity | ECE2017

Comparison between mathematical indexes and histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population

Gutierrez-Aguirre Karen-Ivette , Lazo-de-la-Vega-Monroy Maria-Luisa , Ruiz-Noa Yeniley , Ibarra-Reynoso Lorena-del-Rocio , Garcia-Ramirez Juana-Rosalba , Jordan-Perez Benjamin , Garnelo-Cabanas Serafin , Preciado-Puga Monica-del-Carmen

Introduction: Non-alcoholic fatty liver disease (NAFLD) is an emerging disease in Mexico, comprising a spectrum of histopathological findings ranging from simple steatosis to steatohepatitis and cirrhosis. The gold standard continues to be the liver biopsy, but several mathematical indices have been proposed, such as non-invasive techniques, however there are very few studies in our population.Objetive: This study aims to compare mathematical indexes and...

ea0049ep698 | Obesity | ECE2017

Associations between the dysregulation of splicing machinery components and the development of hepatic steatosis in obese women

del Rio-Moreno Mercedes , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M , Gahete Manuel D

: Hepatic steatosis is a common obesity-associated pathology characterized by the accumulation of fat within the liver, which can progress to liver fibrosis, cirrhosis and ultimately lead to hepatocellular carcinoma. Remarkably, obesity and cancer course with a profound dysregulation of the genetic expression patterns and, particularly, with the aberrant expression of splicing variants that could contribute to the aggressiveness and comorbidities of these pathologies. Since th...

ea0049ep1123 | Female Reproduction | ECE2017

Heterogeneous hCG and hMG commercial preparations result in biased intracellular signaling but induce similar progesterone response in vitro

Riccetti Laura , Klett Daniele , Ayoub Mohammed Akli , Boulo Thomas , Mariot Julie , Pignatti Elisa , Tagliavini Simonetta , Varani Manuela , Tranti Tommaso , Nicoli Alessia , Sala Giovanni Battista La , Combarnous Yves , Reiter Eric , Simoni Manuela , Casarini Livio

Human chorionic gonadotropin (hCG) is the pregnancy hormone marketed as a drug for assisted reproduction technologies to support follicle-stimulating hormone action. Several hCG formulations are commercially available, differing in source, purification methods and biochemical composition. In this study, we investigated the molecular features and the intracellular signaling mediated by five urinary and recombinant hCGs. The drug comparisons were performed by quantifying the hor...

ea0041gp131 | Obesity | ECE2016

The liver of obese patients with hepatic steatosis exhibits a severe dysregulation of key splicing machinery components as compared to obese patients without hepatic steatosis

Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Gahete Manuel D , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M

Obesity, a disease that is growing at epidemic proportions worldwide, is caused by a combination of genetic and lifestyle factors. One of the most common pathologies associated with obesity is hepatic steatosis, an accumulation of fat within the liver that can progress to liver fibrosis, cirrhosis, and ultimately lead to hepatocellular carcinoma. There is emerging evidence that alternative mRNA splicing, the key mechanism providing transcript and protein diversity, is dysregul...

ea0041ep760 | Neuroendocrinology | ECE2016

Morbimortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia

Gomez Hoyos Emilia , Matia Martin Pilar , Ortola Buigues Ana , Crespo Hernandez Irene , Cuesta Hernandez Martin , Perez Ferre Natalia , Angel Rubio Herrera Miguel , De Luis Roman Daniel , Calle Pascual Alfonso , Runkle de la Vega Isabelle

Introduction: Hyponatremia is the most frequent electrolyte disorder found in clinical practice, and has been associated with increased morbimortalty. Hyponatremia is even more common among patients receiving parenteral nutricion(PN), a therapy increasingly in use. However, the morbimortality of hyponatremic patients on PN is unknown.Methods: Retrospective study, selecting all patients receiving PN in a teaching hospital from 01/11/11 to 01/06/12. We eva...

ea0037ep677 | Pituitary: basic and neuroendocrinology | ECE2015

The impact of correcting the serum sodium level for total proteins in patients receiving parenteral nutrition

Hoyos Emilia Gomez , Martin Pilar Matia , Hernandez Martin Cuesta , Gracia Teresa Ruiz , Ferre Natalia Perez , Garcia Lucio Cabrerizo , Herrera Miguel Angel Rubio , De Luis Roman Daniel , Pascual Alfonso Calle , de la Vega Isabelle Runkle

Introduction: In a majority of Spanish hospitals, serum sodium levels (SNa) are determined by indirect electrode methodology (sodium in the liquid fraction of serum) divided by the total serum volume (mmol/l). To avoid over/underestimating SNa, a formula can be applied: SNa corrected for total proteins (TP)=SNa×93 divided by (99.1−(0.7×TP)). Hypoproteinaemia is frequent in patients receiving parenteral nutrition (PN), and is probably related to surgery, acute d...

ea0037ep783 | Pituitary: clinical | ECE2015

Long-term recurrence in nonfunctional pituitary adenomas after surgery

Caballero Maria Galiana Rodriguez , Gallego Nuria Valdes , Blanco Jessica Ares , Ragnarsson Cecilia Sanchez , Cacho Laura , de la Uz Joaquin Pertierra , Artal Antonio Rabal , Gutierrez Lorena Suarez , Delgado Elias , Camblor Pablo Martinez , Faedo Ceferino , Torre Edelmiro Menendez

Object: Nonfunctioning pituitary adenomas can experiment recurrence and/or progression (R/P) several years after surgery in about 15–50% of patients. There is few evidence about risk factors that could predict R/P. The aim of this study is to identify them and describe our experience through a long term of follow-up in pituitary macroadenomas.Methods: Retrospective cohort analysis of 64 patients who underwent surgery between 1990 and 2013. The main ...

ea0035p237 | Clinical case reports Pituitary/Adrenal | ECE2014

Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary

Centeno Rogelio Garcia , Melero Victor Andia , Fernandez Elisa Fernandez , Salas Marcel Sambo , Gonzalez-Antiguedad Cynthia , de la Camara Marta Motilla , Solis Diego Lezcano , Gonzalez Javier , Rivadeneira Lenin , Requena Maria , Ramirez Maria Laura , Olmedilla Yoko , Arnoriaga Maria

Introduction: Although the most common causes of hyperprolactinemia are prolactinoma and iatrogenic, another possible cause is severe primary hypothyroidism, in which the increase of prolactin is a cause of pituitary stimulation by TRH, and can be presented with pituitary hyperplasia.Case report: A 31-year-old woman who comes to endocrinology clinic for hyperprolactinemia, which was detected by symptoms of amenorrhea–galactorrhea. After normal pregn...